Home Cart Sign in  
Chemical Structure| 38976-17-9 Chemical Structure| 38976-17-9

Structure of α-Tocopherol phosphate
CAS No.: 38976-17-9

Chemical Structure| 38976-17-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

α-Tocopherol is the compound demonstrating the highest vitamin E activity, which is available both in its natural form as RRR-alpha-tocopherol isolated from plant sources.

Synonyms: Alpha-Tocopherol phosphate; TocP; αTP

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of α-Tocopherol phosphate

CAS No. :38976-17-9
Formula : C29H51O5P
M.W : 510.69
SMILES Code : O=P(O)(OC1=C(C)C(CC[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)O2)=C2C(C)=C1C)O
Synonyms :
Alpha-Tocopherol phosphate; TocP; αTP
MDL No. :N/A
InChI Key :JUIUXBHZFNHITF-IEOSBIPESA-N
Pubchem ID :94493

Safety of α-Tocopherol phosphate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary porcine embryo fibroblasts 1 nM 3 hours pre-treatment followed by 24 hours OTA exposure Significantly reduced OTA-induced cytotoxicity, LDH release, and DNA damage Toxins (Basel). 2010 Jun;2(6):1265-78
Primary porcine ear fibroblasts 1 nM 3 hours pre-treatment followed by 24 hours OTA exposure Significantly reduced OTA-induced cytotoxicity, LDH release, and DNA damage Toxins (Basel). 2010 Jun;2(6):1265-78

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Chicken embryos Chicken embryo model In ovo injection 0.5 mg or 5.0 mg per egg Single injection, duration 48 hours Α-Tocopherol reduces the harmful effects of acrylamide on acetylcholinesterase (AChE) and can minimize the concentration of malondialdehyde (MDA). Molecules. 2022 Jan 31;27(3):965
Rats Sprague-Dawley rats Subcutaneous injection 10 mg α-tocopherol/100 g Once daily for 3 days To investigate the metabolic pathways of α-tocopherol in the liver, particularly the ω-hydroxylation and β-oxidation processes. Results showed that α-tocopherol metabolism primarily occurs in microsomes, while the final product of β-oxidation, α-CEHC, is predominantly localized in mitochondria. Free Radic Biol Med. 2010 Jan 1;48(1):73-81
Sprague-Dawley rats Cerebral ischemia-reperfusion injury model Subcutaneous injection 100 mg/kg Once daily for one week Α-Tocopherol pretreatment partially ameliorated nerve damage induced by CIRI, reduced oxidative stress and inflammation, and inhibited apoptosis. CNS Neurosci Ther. 2022 Jun;28(6):964-970
C57BL/6 mice Cardiac ischemia/reperfusion injury model Intraperitoneal injection 2.5 mg/kg 2 hours before surgery, immediately after reperfusion, and twice per day for three consecutive days Α-TOH significantly reduced infarct size, restored cardiac function, decreased neutrophil infiltration, and systemic inflammatory response Redox Biol. 2019 Sep;26:101292
Male Sprague Dawley rats Cisplatin-induced nephrotoxicity model Intraperitoneal injection 250 mg/kg Single injection, lasting 10 days Α-Tocopherol significantly ameliorated cisplatin-induced nephrotoxicity by enhancing antioxidant status and reducing inflammatory responses. Molecules. 2022 Mar 28;27(7):2179
Nude mice A431 human squamous carcinoma xenograft model Topical application 75 mg/mL On day 3 and 10 To evaluate the antitumor efficacy of topical CTX in 30% DMSO/α-tocopherol. Results showed significant tumor suppression at high concentration (75 mg/mL), while lower concentrations (25 and 50 mg/mL) had minimal effect. Adv Sci (Weinh). 2023 Oct;10(29):e2302658.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.96mL

0.39mL

0.20mL

9.79mL

1.96mL

0.98mL

19.58mL

3.92mL

1.96mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories